Seeing Is Believing
Currently out of the existing stock ratings of Anne Edelstein, 5 are a BUY (100%).
Analyst Anne Edelstein, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 100% that have a potential upside of 12.87% achieved within 55 days. Previously, Anne Edelstein worked at BAML.
Anne Edelstein’s has documented 10 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXAS, EXACT Sciences at 29-Nov-2017.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/19/2017. The price target of $56 was fulfilled within 15 days with a profit of $8.47 (17.82%) receiving and performance score of 11.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$55
$13.42 (32.28%)
$65
11 days ago
(10-Apr-2025)
0/3 (0%)
$11.26 (25.74%)
Buy
$70
$28.42 (68.35%)
$75
1 months 26 days ago
(26-Feb-2025)
4/10 (40%)
$19.82 (39.50%)
31
Buy
$65
$23.42 (56.33%)
$65
3 months 8 days ago
(13-Jan-2025)
10/13 (76.92%)
$6.49 (11.09%)
151
Buy
$72
$30.42 (73.16%)
$88
4 months 8 days ago
(13-Dec-2024)
2/3 (66.67%)
$10.75 (17.55%)
225
Buy
$75
$33.42 (80.38%)
$65
4 months 26 days ago
(26-Nov-2024)
37/45 (82.22%)
$14.9 (24.79%)
162
What Year was the first public recommendation made by Anne Edelstein?